HOME  |  ABOUT LGS  |  ABOUT LGSF  |  CONTACT  |  DONATE 

 

© 2019 LGS FOUNDATION

This website is not intended to serve as medical advice. Please read our full disclaimer

LGS Foundation Announces 2015 Research Grant Recipients 

 

New York, NY (June 9, 2015) — The Lennox-Gastaut Syndrome Foundation (LGS Foundation) announced today the recipients of their  2015 grant cycle for research in Lennox-Gastaut Syndrome. Robert Hunt, PhD from the University of California Irvine and Candace Myers, PhD from the University of Washington are those selected to receive funding from the LGS Foundation. 

 

 “In the 8 years since its founding, the LGS Foundation has supported a number of projects aimed at better understanding the underlying causes of Lennox-Gastaut Syndrome and to find new and effective treatments for the disorder” says LGS Foundation President and Executive Director, Christina SanInocencio.

 

Dr. Hunt’s lab will receive a one year, $30,000 seed grant that will help to generate a CHD2 animal model of LGS. "Our lab will generate mice with a gene mutation linked to LGS. We will study how the brain develops in these mice and whether they have multiple types of seizures. A successful outcome of this work will establish a genetic mouse model of LGS that can be used to test new treatments designed specifically for this form of epilepsy," says Dr. Hunt.

 

Dr. Myers will receive a two year, $50,000 post-doctoral fellowship to help identify the genetic causes of Lennox-Gastaut Syndrome. “This project aims to identify novel genetic causes of LGS, investigate genotype-phenotype correlations, and organize all findings so they are accessible worldwide. By understanding the genetic causes of LGS, new avenues for targeted therapies can be explored and hopefully lead to a cure,” says Dr. Myers.

 

"We are thrilled to be supporting these much needed research efforts for Lennox-Gastaut Syndrome,” says Melanie Huntley, PhD, LGS Foundation Board Member and Research Liaison. “These studies fuel the hope for a better future for our loved ones afflicted by this catastrophic form of epilepsy."

 

Other ongoing research funded by the LGS Foundation includes a zebrafish model of the GABRB3 mutation linked to LGS, which was awarded to Brian Grone, PhD from the University of California, San Francisco in 2014, and a study to examine the efficacy of the Low Glycemic Index Treatment in Patients with LGS, which was awarded to Elizabeth Thiele, MD, PhD from Massachusetts General Hospital in 2014.

 

About the LGS Foundation

The LGS Foundation is a non-profit organization dedicated to improving the lives of individuals living with Lennox-Gastaut Syndrome, a rare and catastrophic form of childhood-onset epilepsy, through research, programs, and education.  For more information, visit www.lgsfoundation.org.

###